Search

Monica E. Millner

Examiner (ID: 13456, Phone: (571)270-7507 , Office: P/3632 )

Most Active Art Unit
3632
Art Unit(s)
3632, 3627, 3508
Total Applications
1500
Issued Applications
1152
Pending Applications
94
Abandoned Applications
283

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 5922971 [patent_doc_number] => 20020115607 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-22 [patent_title] => 'Protein-protein interactions in neurodegenerative diseases' [patent_app_type] => new [patent_app_number] => 09/975072 [patent_app_country] => US [patent_app_date] => 2001-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26414 [patent_no_of_claims] => 136 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 323 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0115/20020115607.pdf [firstpage_image] =>[orig_patent_app_number] => 09975072 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/975072
Protein-protein interactions in neurodegenerative diseases Oct 11, 2001 Abandoned
Array ( [id] => 6082309 [patent_doc_number] => 20020082215 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-27 [patent_title] => 'Method for treating ischemic events affecting the central nervous system' [patent_app_type] => new [patent_app_number] => 09/976620 [patent_app_country] => US [patent_app_date] => 2001-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 15644 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20020082215.pdf [firstpage_image] =>[orig_patent_app_number] => 09976620 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/976620
Method for treating ischemic events affecting the central nervous system Oct 11, 2001 Abandoned
Array ( [id] => 5921099 [patent_doc_number] => 20020114799 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-22 [patent_title] => 'Protein-protein interactions in neurodegenerative diseases' [patent_app_type] => new [patent_app_number] => 09/973077 [patent_app_country] => US [patent_app_date] => 2001-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26412 [patent_no_of_claims] => 79 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0114/20020114799.pdf [firstpage_image] =>[orig_patent_app_number] => 09973077 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/973077
Protein-protein interactions in neurodegenerative diseases Oct 9, 2001 Abandoned
Array ( [id] => 6761342 [patent_doc_number] => 20030124704 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-03 [patent_title] => 'Nogo receptor homologs' [patent_app_type] => new [patent_app_number] => 09/972546 [patent_app_country] => US [patent_app_date] => 2001-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 52016 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20030124704.pdf [firstpage_image] =>[orig_patent_app_number] => 09972546 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/972546
Nogo receptor homologs Oct 5, 2001 Abandoned
Array ( [id] => 1311886 [patent_doc_number] => 06610538 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-08-26 [patent_title] => 'Reconstructed laminae of human epithelium corneae and method of producing the same' [patent_app_type] => B2 [patent_app_number] => 09/961314 [patent_app_country] => US [patent_app_date] => 2001-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 5 [patent_no_of_words] => 3554 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 101 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/610/06610538.pdf [firstpage_image] =>[orig_patent_app_number] => 09961314 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/961314
Reconstructed laminae of human epithelium corneae and method of producing the same Sep 24, 2001 Issued
Array ( [id] => 7964271 [patent_doc_number] => 06680292 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-01-20 [patent_title] => 'Pharmaceutical composition comprising ribavirin and growth factors and methods of use' [patent_app_type] => B1 [patent_app_number] => 09/856100 [patent_app_country] => US [patent_app_date] => 2001-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 11 [patent_no_of_words] => 10879 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/680/06680292.pdf [firstpage_image] =>[orig_patent_app_number] => 09856100 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/856100
Pharmaceutical composition comprising ribavirin and growth factors and methods of use Sep 23, 2001 Issued
09/890579 Method for inducing differentiation into adipocytes, compounds controlling such differentiation and method of screening for same Sep 18, 2001 Abandoned
Array ( [id] => 1080407 [patent_doc_number] => 06835565 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-12-28 [patent_title] => 'Alzheimer\'s disease secretase' [patent_app_type] => B1 [patent_app_number] => 09/806194 [patent_app_country] => US [patent_app_date] => 2001-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 12 [patent_no_of_words] => 38637 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/835/06835565.pdf [firstpage_image] =>[orig_patent_app_number] => 09806194 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/806194
Alzheimer's disease secretase Sep 16, 2001 Issued
Array ( [id] => 5788281 [patent_doc_number] => 20020160933 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-31 [patent_title] => 'Methods and compositions for producing a neurosalutary effect in a subject' [patent_app_type] => new [patent_app_number] => 09/949200 [patent_app_country] => US [patent_app_date] => 2001-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 14975 [patent_no_of_claims] => 58 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20020160933.pdf [firstpage_image] =>[orig_patent_app_number] => 09949200 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/949200
Methods and compositions for producing a neurosalutary effect in a subject Sep 6, 2001 Abandoned
Array ( [id] => 6778169 [patent_doc_number] => 20030049250 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-13 [patent_title] => 'Method for enhancing endothelial function in humans' [patent_app_type] => new [patent_app_number] => 09/946174 [patent_app_country] => US [patent_app_date] => 2001-09-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7778 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0049/20030049250.pdf [firstpage_image] =>[orig_patent_app_number] => 09946174 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/946174
Method for enhancing endothelial function in humans Sep 4, 2001 Abandoned
Array ( [id] => 6567354 [patent_doc_number] => 20020165144 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-07 [patent_title] => 'Human schizophrenia gene' [patent_app_type] => new [patent_app_number] => 09/946807 [patent_app_country] => US [patent_app_date] => 2001-09-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 27004 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0165/20020165144.pdf [firstpage_image] =>[orig_patent_app_number] => 09946807 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/946807
Human schizophrenia gene Sep 4, 2001 Abandoned
Array ( [id] => 1245520 [patent_doc_number] => 06677124 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-01-13 [patent_title] => 'Monoclonal antibody recognizing C-terminus of hBNP' [patent_app_type] => B2 [patent_app_number] => 09/942709 [patent_app_country] => US [patent_app_date] => 2001-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5755 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/677/06677124.pdf [firstpage_image] =>[orig_patent_app_number] => 09942709 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/942709
Monoclonal antibody recognizing C-terminus of hBNP Aug 30, 2001 Issued
Array ( [id] => 1248072 [patent_doc_number] => 06673603 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-01-06 [patent_title] => 'Cell paste comprising keratinocytes and fibroblasts' [patent_app_type] => B2 [patent_app_number] => 09/943114 [patent_app_country] => US [patent_app_date] => 2001-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 8833 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 102 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/673/06673603.pdf [firstpage_image] =>[orig_patent_app_number] => 09943114 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/943114
Cell paste comprising keratinocytes and fibroblasts Aug 29, 2001 Issued
Array ( [id] => 1005223 [patent_doc_number] => 06905815 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-06-14 [patent_title] => 'Method of screening for inhibitors of VCP binding to polyglutamine, abeta, alpha-synuclein, and sod1' [patent_app_type] => utility [patent_app_number] => 10/111373 [patent_app_country] => US [patent_app_date] => 2001-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 5122 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 95 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/905/06905815.pdf [firstpage_image] =>[orig_patent_app_number] => 10111373 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/111373
Method of screening for inhibitors of VCP binding to polyglutamine, abeta, alpha-synuclein, and sod1 Aug 23, 2001 Issued
Array ( [id] => 1095640 [patent_doc_number] => 06821743 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-11-23 [patent_title] => 'Human endothelin receptor' [patent_app_type] => B2 [patent_app_number] => 09/931157 [patent_app_country] => US [patent_app_date] => 2001-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 7756 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/821/06821743.pdf [firstpage_image] =>[orig_patent_app_number] => 09931157 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/931157
Human endothelin receptor Aug 15, 2001 Issued
Array ( [id] => 6838771 [patent_doc_number] => 20030036111 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-20 [patent_title] => 'Mitochondrial protein' [patent_app_type] => new [patent_app_number] => 09/923921 [patent_app_country] => US [patent_app_date] => 2001-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 13298 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0036/20030036111.pdf [firstpage_image] =>[orig_patent_app_number] => 09923921 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/923921
Mitochondrial protein Aug 6, 2001 Abandoned
Array ( [id] => 1208904 [patent_doc_number] => 06713246 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-03-30 [patent_title] => 'Method of producing interleukin-1 receptor antagonist in a syringe filled with blood' [patent_app_type] => B1 [patent_app_number] => 09/890723 [patent_app_country] => US [patent_app_date] => 2001-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 7340 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/713/06713246.pdf [firstpage_image] =>[orig_patent_app_number] => 09890723 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/890723
Method of producing interleukin-1 receptor antagonist in a syringe filled with blood Jul 31, 2001 Issued
09/674292 Induction of neuronal regeneration Jul 31, 2001 Abandoned
Array ( [id] => 1253178 [patent_doc_number] => 06670179 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-12-30 [patent_title] => 'Molecular functionalization of carbon nanotubes and use as substrates for neuronal growth' [patent_app_type] => B1 [patent_app_number] => 09/920213 [patent_app_country] => US [patent_app_date] => 2001-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 2766 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/670/06670179.pdf [firstpage_image] =>[orig_patent_app_number] => 09920213 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/920213
Molecular functionalization of carbon nanotubes and use as substrates for neuronal growth Jul 31, 2001 Issued
Array ( [id] => 5873792 [patent_doc_number] => 20020048746 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-04-25 [patent_title] => 'Model for alzheimer\'s disease and other neurodegenerative diseases' [patent_app_type] => new [patent_app_number] => 09/917789 [patent_app_country] => US [patent_app_date] => 2001-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 37262 [patent_no_of_claims] => 94 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20020048746.pdf [firstpage_image] =>[orig_patent_app_number] => 09917789 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/917789
Model for Alzheimer's disease and other neurodegenerative diseases Jul 30, 2001 Issued
Menu